Herein, we consider venous immunothrombotic mechanisms in SARS-CoV-2 infection and
anti-SARS-CoV-2 DNA vaccination. Primary SARS-CoV-2 infection with systemic viral RNA …

Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …

Abstract SARS-CoV-2 vaccine ChAdOx1 nCoV-19 (AstraZeneca) causes a thromboembolic
complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT). Using …

Organisation mondiale de la Santé 2022 Certains droits réservés. La présente œuvre est
disponible sous la licence Creative Commons Attribution Pas d'utilisation commerciale …

End-stage renal disease (ESRD) patients on chronic hemodialysis have repeated blood
exposure to artificial surfaces that can trigger clot formation within the hemodialysis circuit …

Vaccine-induced immune thrombotic thrombocytopenia (VITT; synonym, thrombosis with
thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies …

Vaccine-induced thrombotic thrombocytopenia (VITT) is triggered by vaccination against
COVID-19 with adenovirus vector vaccines (ChAdOx1 nCoV-19; Ad26. COV2-S). In this …

Platelet-activating anti-platelet factor 4 (PF4)/heparin antibodies and anti-PF4 antibodies
cause heparin-induced thrombocytopenia (HIT) and vaccine-induced immune …

Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …

Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct
thrombin inhibitors are considered by some potentially advantageous over unfractionated …